tradingkey.logo

Harvard Bioscience Inc

HBIO
查看详细走势图
0.753USD
-0.014-1.79%
收盘 12/19, 16:00美东报价延迟15分钟
33.59M总市值
亏损市盈率 TTM

Harvard Bioscience Inc

0.753
-0.014-1.79%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.79%

5天

+1.70%

1月

+34.15%

6月

+41.72%

今年开始到现在

-64.29%

1年

-64.29%

查看详细走势图

TradingKey Harvard Bioscience Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Harvard Bioscience Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名126/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.00。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Harvard Bioscience Inc评分

相关信息

行业排名
126 / 208
全市场排名
295 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
买入
评级
2.000
目标均价
+164.27%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Harvard Bioscience Inc亮点

亮点风险
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
业绩增长期
公司处于发展阶段,最新年度总收入94.14M美元
利润高增长
公司净利润处于行业前列,最新年度总收入94.14M美元
估值高估
公司最新PE估值-0.62,处于3年历史高位
机构减仓
最新机构持股25.97M股,环比减少25.10%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值868.48K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.72

Harvard Bioscience Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Harvard Bioscience Inc简介

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
公司代码HBIO
公司Harvard Bioscience Inc
CEODuke (John D)
网址https://www.harvardbioscience.com/

常见问题

Harvard Bioscience Inc(HBIO)的当前股价是多少?

Harvard Bioscience Inc(HBIO)的当前股价是 0.753。

Harvard Bioscience Inc的股票代码是什么?

Harvard Bioscience Inc的股票代码是HBIO。

Harvard Bioscience Inc股票的52周最高点是多少?

Harvard Bioscience Inc股票的52周最高点是2.280。

Harvard Bioscience Inc股票的52周最低点是多少?

Harvard Bioscience Inc股票的52周最低点是0.281。

Harvard Bioscience Inc的市值是多少?

Harvard Bioscience Inc的市值是33.59M。

Harvard Bioscience Inc的净利润是多少?

Harvard Bioscience Inc的净利润为-12.40M。

现在Harvard Bioscience Inc(HBIO)的股票是买入、持有还是卖出?

根据分析师评级,Harvard Bioscience Inc(HBIO)的总体评级为买入,目标价格为2.000。

Harvard Bioscience Inc(HBIO)股票的每股收益(EPS TTM)是多少

Harvard Bioscience Inc(HBIO)股票的每股收益(EPS TTM)是-1.214。
KeyAI